All Stories

  1. Performance of perpendicular drop versus tangent skimming gating of M-protein in proficiency testing challenges
  2. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis
  3. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins
  4. Vedolizumab quantitation using high-resolution accurate mass-mass spectrometry middle-up protein subunit: method validation
  5. Correlation Between Kappa Prozone Effect and IgA Kappa M Proteins in Serum Free Light-Chain Assay
  6. Replacing Oligoclonal Banding by Detecting CSF Free Light Chains in Demyelinating Disease
  7. Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to Infliximab
  8. Therapeutic Monoclonal Antibodies in the Clinical Laboratory
  9. Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical Laboratory
  10. Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
  11. Implementation of Clinical Decision Support Rules to Reduce Repeat Measurement of Serum Ionized Calcium, Serum Magnesium, and N-Terminal Pro-B-Type Natriuretic Peptide in Intensive Care Unit Inpatients
  12. Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease
  13. Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
  14. Therapeutic monoclonal antibodies seen on protein electrophoresis
  15. Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry
  16. A Dark-Brown Serum Sample
  17. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases
  18. Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry
  19. Sa1268 Clinical Development of an Electrochemiluminescent Immunoassay to Measure Antibodies-to-Infliximab
  20. Sa1252 Serum Infliximab Quantitation by LC-MS/MS in Patients Treated for Inflammatory Disorders
  21. Statin regulation of CYP3A4 and CYP3A5 expression
  22. CYP3A5⁎3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
  23. Estudo da expressão gênica e de polimorfismos da CYP3A5 em pacientes com hipercolesterolemia tratados com atorvastatina
  24. Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo